Lung Cancer

Lung cancer is one of the most prevalent and lethal cancers globally, responsible for over 2 million new cases and approximately 1.8 million deaths annually, according to the World Health Organization (WHO). As the leading cause of cancer-related deaths worldwide, lung cancer affects both smokers and non-smokers, although smoking remains the primary risk factor. This article delves into the various aspects of lung cancer, from causes and symptoms to diagnosis, treatment, and prevention.

Lung Cancer types:

Lung cancer is broadly categorized into two main types, based on the cells affected:

1. Non-Small Cell Lung Cancer (NSCLC): The most common form, accounting for approximately 85% of lung cancer cases. NSCLC can be further classified into subtypes, including:
   • Adenocarcinoma: The most prevalent subtype, often seen in non-smokers and women. It originates in the mucus-producing cells of the lung.
   • Squamous Cell Carcinoma: Typically linked to smoking, it develops in the flat cells lining the inside of the lungs.
   • Large Cell Carcinoma: A less common and more aggressive form of NSCLC that can appear in any part of the lung.
2. Small Cell Lung Cancer (SCLC): This type accounts for about 10-15% of lung cancers and is more aggressive, spreading rapidly to other parts of the body. SCLC is strongly associated with smoking.

Lung Cancer causes:

While smoking is the leading cause of lung cancer, accounting for around 85% of cases, other factors can also contribute to the development of the disease. Here are some key causes and risk factors:

1. Tobacco Smoke: The primary risk factor for lung cancer is cigarette smoking, as tobacco smoke contains over 7,000 chemicals, many of which are carcinogenic. The risk of lung cancer increases with the number of cigarettes smoked and the duration of smoking.
2. Secondhand Smoke: Non-smokers exposed to secondhand smoke (environmental tobacco smoke) are also at risk. Long-term exposure can significantly increase the likelihood of developing lung cancer.
3. Radon Gas: Radon is a naturally occurring radioactive gas that can accumulate in homes and buildings. Prolonged exposure to high levels of radon can damage the cells in the lungs and lead to cancer.
4. Asbestos Exposure: Asbestos, once commonly used in construction and manufacturing, can cause lung cancer when inhaled. People who have worked with asbestos, such as in construction or shipyards, are at higher risk.
5. Air Pollution: Long-term exposure to air pollution, particularly fine particulate matter (PM2.5), has been linked to an increased risk of lung cancer. Industrial emissions, vehicle exhaust, and the burning of fossil fuels contribute to air pollution.
6. Family History: A genetic predisposition may increase the likelihood of developing lung cancer. Individuals with a family history of lung cancer have a higher risk, even if they do not smoke.
7. Prior Radiation Therapy: People who have undergone radiation therapy to the chest, such as for breast cancer or lymphoma, may have a heightened risk of lung cancer.

Lung Cancer symptoms:

Lung cancer often does not cause noticeable symptoms in its early stages, which is one reason it is frequently diagnosed at an advanced stage. However, as the disease progresses, the following symptoms may appear:

• Persistent Cough: A chronic cough that worsens over time or does not go away can be a sign of lung cancer. A change in the nature of a smoker’s cough is also concerning.
• Coughing Up Blood (Hemoptysis): Blood in sputum, even in small amounts, should never be ignored and requires immediate medical attention.
• Shortness of Breath: Difficulty breathing or a feeling of breathlessness, even during everyday activities, may indicate lung cancer.
• Chest Pain: Pain in the chest, shoulder, or back can occur, especially if the cancer invades nearby tissues or spreads to the chest wall.
• Unexplained Weight Loss: Sudden and significant weight loss without an obvious cause can be a sign of many cancers, including lung cancer.
• Fatigue: Persistent and unexplained fatigue is common in cancer patients.
• Hoarseness: If a tumor presses on the nerves controlling the vocal cords, it can cause hoarseness or a change in voice.
• Bone Pain: If lung cancer spreads to the bones, it can cause severe pain, particularly in the back or ribs.

Diagnosis of Lung Cancer:

When lung cancer is suspected, several diagnostic tests are used to confirm the diagnosis and determine the extent (stage) of the disease:

1. Imaging Tests:
   • Chest X-Ray: An initial test that may reveal a mass or nodule in the lungs.
   • CT Scan (Computed Tomography): Provides more detailed images of the lungs and surrounding tissues and helps determine the size, shape, and location of the tumor.
   • PET Scan (Positron Emission Tomography): This test helps detect areas of high metabolic activity, which may indicate cancer.
2. Sputum Cytology: Examining a sample of sputum (mucus) under a microscope can sometimes detect cancer cells.
3. Biopsy: A definitive diagnosis often requires a biopsy, where a tissue sample is removed and examined for cancer cells. This can be done using several methods:
   • Bronchoscopy: A thin, flexible tube (bronchoscope) is inserted into the lungs through the mouth or nose to collect tissue samples.
   • Needle Biopsy: A needle is inserted through the chest wall to remove a sample from the lung tumor.
   • Surgical Biopsy: In some cases, a more invasive procedure may be needed to remove a larger tissue sample.
4. Molecular Testing: To guide treatment, molecular testing of the tumor may be done to identify specific genetic mutations or proteins that could be targeted with specific therapies.

Lung Cancer stages:

Lung cancer staging is a critical part of determining the extent of cancer in the body and helps guide treatment and prognosis. There are two primary types of lung cancer—non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC)—and the staging for each is distinct. Let’s explore both in detail.

Non-Small Cell Lung Cancer (NSCLC) Staging:

The TNM staging system is used for NSCLC, which classifies cancer into stages based on three factors:

• T (Tumor): Size and extent of the primary tumor.
• N (Nodes): Whether cancer has spread to nearby lymph nodes.
• M (Metastasis): Whether cancer has spread to other parts of the body.

Based on these factors, NSCLC is divided into five main stages (Stage 0 to Stage IV):

Stage 0 (In Situ):

• T: The cancer is localized and small. It is limited to the top layers of lung tissue (carcinoma in situ) and has not invaded deeper tissues.
• N: No lymph node involvement.
• M: No distant metastasis.

This stage is very early and indicates that cancer has not spread beyond its origin. It is usually highly treatable, often curable with surgery.

Stage I (Localized Cancer):

• T1: The tumor is 3 cm or smaller and limited to the lung. It has not invaded surrounding tissues.
• N0: No lymph nodes are affected.
• M0: No metastasis.
• T2a: Tumor is larger than 3 cm but not more than 4 cm.

Cancer in Stage I is still localized, and surgery is often the primary treatment option, sometimes followed by chemotherapy or radiation therapy to ensure all cancer cells are eradicated.

Stage II (Regional Spread):

• T2b: Tumor is larger than 4 cm but not more than 5 cm.
• T3: Tumor is larger than 5 cm or invades nearby structures such as the chest wall.
• N1: Cancer has spread to nearby lymph nodes inside the lung or around the area where the main bronchus branches.
• M0: No metastasis.

In Stage II, the tumor may have started spreading to nearby tissues or lymph nodes. Surgery, chemotherapy, and radiation therapy are common treatment options.

Stage III (Locally Advanced):

Stage III is divided into Stage IIIA, Stage IIIB, and Stage IIIC, depending on the extent of lymph node involvement and the size or spread of the tumor.

• T3-T4: Tumors are larger than 7 cm or invade nearby organs (heart, trachea, esophagus) or cause other problems (such as collapsing the lung).
• N2: Cancer has spread to lymph nodes in the center of the chest on the same side as the tumor.
• N3: Cancer has spread to lymph nodes on the opposite side of the chest or above the collarbone.
• M0: No distant metastasis.

Stage III is generally considered advanced, and treatment often includes a combination of surgery, chemotherapy, and radiation therapy. In some cases, targeted therapies or immunotherapies are used.

Stage IV (Metastatic):

Stage IV NSCLC means the cancer has spread beyond the lungs to other parts of the body, such as the bones, liver, brain, or adrenal glands.

• M1a: Cancer has spread within the chest, affecting the pleura (lining of the lungs) or causing pleural effusion (fluid buildup around the lungs).
• M1b: A single tumor has spread to one other distant organ or outside the chest.
• M1c: Multiple tumors have spread to multiple organs.

Treatment for Stage IV is typically not curative but focuses on extending life and relieving symptoms. Treatment may include chemotherapy, targeted therapy, immunotherapy, or a combination.

Small Cell Lung Cancer (SCLC) Staging:

SCLC tends to grow and spread more rapidly than NSCLC. Due to its aggressive nature, SCLC has a simpler staging system, consisting of limited-stage and extensive-stage categories. About two-thirds of SCLC cases are diagnosed in the extensive stage.

Limited-Stage SCLC:

• Cancer is confined to one lung and possibly the nearby lymph nodes, typically on the same side of the chest.
• The disease can often be treated within a single radiation field (meaning the cancer is localized enough for radiation therapy to target it effectively).

Treatment for limited-stage SCLC may involve chemotherapy combined with radiation therapy. In some cases, surgery may be an option if the tumor is small and confined to one area.

Extensive-Stage SCLC:

• Cancer has spread beyond one lung, either to the other lung, to lymph nodes on the opposite side of the chest, or to other parts of the body (such as the brain, liver, or bones).

Since extensive-stage SCLC is widespread at the time of diagnosis, surgery is not typically an option. Treatment often includes chemotherapy and possibly radiation therapy to control symptoms, prevent complications, and extend survival.

Recurrent Lung Cancer:

Recurrent lung cancer refers to cancer that returns after treatment, either in the lung (local recurrence) or elsewhere in the body (distant recurrence). Treatment for recurrent cancer depends on where it recurs, the type of cancer, and previous treatments.

Factors Influencing Staging and Prognosis:

Staging is essential in determining the prognosis and treatment plan for lung cancer. However, other factors can also influence outcomes, including:

1. Tumor Size and Location: Larger tumors or those in difficult-to-treat locations may be harder to remove completely.
2. Genetic Mutations: Specific genetic mutations, such as EGFR, ALK, or ROS1, can make the cancer more responsive to targeted therapies, which may improve outcomes.
3. Overall Health: A patient’s age, overall health, and lung function play a role in treatment choices and prognosis.
4. Smoking Status: Patients who quit smoking before or after their diagnosis often have a better prognosis than those who continue smoking.

Lung Cancer treatment:

The treatment of lung cancer depends on the type, stage, and overall health of the patient. It may involve one or a combination of the following therapies:

1. Surgery: Surgical removal of the tumor is an option for patients with early-stage lung cancer (typically Stage I and some Stage II). Types of surgery include:
   • Lobectomy: Removal of an entire lobe of the lung.
   • Pneumonectomy: Removal of one entire lung.
   • Segmentectomy or Wedge Resection: Removal of a smaller portion of the lung, often used when the patient’s lung function is compromised.
2. Radiation Therapy: High-energy beams are used to kill cancer cells or shrink tumors. It can be used as the primary treatment, especially in patients who are not candidates for surgery, or after surgery to eliminate any remaining cancer cells.
3. Chemotherapy: Chemotherapy involves the use of drugs to kill rapidly dividing cancer cells. It is often used in combination with other treatments and is particularly common in treating advanced-stage lung cancer.
4. Targeted Therapy: This treatment focuses on specific genetic mutations or abnormalities in cancer cells. Drugs like Erlotinib and Gefitinib target the EGFR mutation, while Crizotinib targets the ALK mutation. Targeted therapy tends to have fewer side effects than chemotherapy.
5. Immunotherapy: Immunotherapy helps the immune system recognize and attack cancer cells. Drugs like Pembrolizumab (Keytruda) and Nivolumab (Opdivo) are examples of immunotherapies used in lung cancer treatment.
6. Palliative Care: In advanced cases, where cure is unlikely, palliative care focuses on managing symptoms and improving the patient’s quality of life.

Treatment Approaches Based on Stage:

• Stage I and II: Surgery is often the preferred treatment, especially if the tumor is localized. Radiation and chemotherapy may be used as adjuvant treatments.
• Stage III: A combination of therapies, including chemotherapy, radiation, and sometimes surgery, is typically used. Immunotherapy has also shown promise in treating advanced NSCLC.
• Stage IV: Palliative care becomes the focus to manage symptoms and prolong life. Chemotherapy, immunotherapy, and targeted therapies are the primary treatment modalities.

Prevention of Lung Cancer:

Although lung cancer is a devastating disease, it is largely preventable by addressing the primary risk factors:

1. Quit Smoking: The single most effective way to prevent lung cancer is to stop smoking. Even long-term smokers can significantly reduce their risk by quitting.
2. Avoid Secondhand Smoke: Avoiding environments where people smoke can lower the risk of lung cancer.
3. Test for Radon: Testing homes for radon and reducing radon levels when necessary can minimize exposure to this radioactive gas.
4. Protect Against Occupational Hazards: Workers exposed to asbestos or other carcinogens should take precautions to minimize exposure.
5. Maintain Air Quality: Supporting policies that reduce air pollution and avoiding outdoor activities on days with high pollution levels can help reduce the risk of lung cancer.

Lung cancer remains a significant global health challenge, but advances in early detection, targeted treatments, and personalized medicine are improving outcomes for patients. Prevention efforts, especially smoking cessation, and awareness of risk factors can significantly reduce the incidence of this deadly disease. Early diagnosis and personalized treatment approaches are key to improving survival and quality of life for those affected by lung cancer.

To consult a Doctor at Sparsh Diagnostic Centre, call our helpline number 9830117733.

#BhaloTheko

Disclaimer:

Additional Reading:

• https://www.who.int/health-topics/cancer#tab=tab_1